capecitabine has been researched along with indocyanine green in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baek, J; Lee, J; Ra, H | 1 |
1 review(s) available for capecitabine and indocyanine green
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for capecitabine and indocyanine green
| Article | Year |
|---|---|
Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema.
Topics: Adult; Albumin-Bound Paclitaxel; Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Macular Edema; Oxaliplatin; Pancreatic Neoplasms; Tomography, Optical Coherence | 2019 |